Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Accenture
Harvard Business School
Chinese Patent Office
McKinsey
Argus Health

Generated: March 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Dapagliflozin; Metformin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00528879 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Completed Bristol-Myers Squibb Phase 3 The purpose of this clinical research study is to learn whether dapagliflozin can help reduce blood sugar levels in participants with Type 2 diabetes that is not well controlled on metformin alone. The safety of this treatment will also be studied.
NCT00528879 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Completed AstraZeneca Phase 3 The purpose of this clinical research study is to learn whether dapagliflozin can help reduce blood sugar levels in participants with Type 2 diabetes that is not well controlled on metformin alone. The safety of this treatment will also be studied.
NCT00546741 Drug Interaction With Metformin Completed AstraZeneca Phase 1 The purpose of the study is to determine the effect of metformin on dapagliflozin exposure and the effect of dapagliflozin on metformin exposure in healthy volunteers. Additionally, the safety and tolerability of dapagliflozin will be assessed in the presence and absence of metformin in healthy volunteers
NCT00643851 An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets Completed AstraZeneca Phase 3 The purpose of this clinical research study is to learn if initiating treatment with BMS-51248 (Dapagliflozin) in combination with metformin XR can improve diabetes control in patients with Type 2 Diabetes who do not receive any pharmacological treatment for diabetes, when compared to initial treatment with monotherapy dapagliflozin or metformin XR. The safety of this treatment will also be studied
NCT00660907 Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients Completed Bristol-Myers Squibb Phase 3 This study is being carried out to see if dapagliflozin as an addition to metformin is effective and safe in treating patients with type 2 diabetes when compared to glipizide (sulphonylurea) as an addition to metformin treatment.
NCT00660907 Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients Completed AstraZeneca Phase 3 This study is being carried out to see if dapagliflozin as an addition to metformin is effective and safe in treating patients with type 2 diabetes when compared to glipizide (sulphonylurea) as an addition to metformin treatment.
NCT00855166 Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes Completed Bristol-Myers Squibb Phase 3 This study is being carried out to see if dapagliflozin in addition to metformin decreases body weight and if so, how it compares with metformin alone.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Dapagliflozin; Metformin Hydrochloride

Condition Name

Condition Name for Dapagliflozin; Metformin Hydrochloride
Intervention Trials
Type 2 Diabetes 16
Diabetes Mellitus, Type 2 14
Type 2 Diabetes Mellitus 14
Obesity 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dapagliflozin; Metformin Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 54
Diabetes Mellitus 49
Prediabetic State 3
Glucose Intolerance 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dapagliflozin; Metformin Hydrochloride

Trials by Country

Trials by Country for Dapagliflozin; Metformin Hydrochloride
Location Trials
United States 267
Mexico 39
Canada 35
United Kingdom 18
Korea, Republic of 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dapagliflozin; Metformin Hydrochloride
Location Trials
Texas 19
Florida 15
California 14
Ohio 12
Arizona 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dapagliflozin; Metformin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dapagliflozin; Metformin Hydrochloride
Clinical Trial Phase Trials
Phase 4 28
Phase 3 25
Phase 2 4
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dapagliflozin; Metformin Hydrochloride
Clinical Trial Phase Trials
Recruiting 25
Completed 24
Not yet recruiting 17
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dapagliflozin; Metformin Hydrochloride

Sponsor Name

Sponsor Name for Dapagliflozin; Metformin Hydrochloride
Sponsor Trials
AstraZeneca 48
Bristol-Myers Squibb 11
The University of Texas Health Science Center at San Antonio 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dapagliflozin; Metformin Hydrochloride
Sponsor Trials
Industry 67
Other 52
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Baxter
Boehringer Ingelheim
Covington
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.